ArticlemAbs

Restoring the biological activity of crizanlizumab at physiological conditions through a pH-dependent aspartic acid isomerization reaction.

Fabian Bickel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.